Search Results for: RGS4

21 interactions involving RGS4 - regulator of G protein signaling 4 found:

Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
BYSL bystin like
  • Major pathway of rRNA processing in the nucleolus and cytosol
CALM1 calmodulin 1
  • CaMK IV-mediated phosphorylation of CREB
  • CaMK IV-mediated phosphorylation of CREB
  • Calmodulin induced events
  • Cam-PDE 1 activation
  • CaM pathway
  • Platelet degranulation
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
  • PKA activation
  • DARPP-32 events
  • Synthesis of IP3 and IP4 in the cytosol
  • Calcineurin activates NFAT
  • Calcineurin activates NFAT
  • eNOS activation
  • Transcriptional activation of mitochondrial biogenesis
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Inactivation, recovery and regulation of the phototransduction cascade
  • Stimuli-sensing channels
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Ca2+ pathway
  • Reduction of cytosolic Ca++ levels
  • Sodium/Calcium exchangers
  • Unblocking of NMDA receptors, glutamate binding and activation
  • CREB1 phosphorylation through the activation of Adenylate Cyclase
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde
  • Ras activation upon Ca2+ influx through NMDA receptor
  • Smooth Muscle Contraction
  • Smooth Muscle Contraction
  • Activation of Ca-permeable Kainate Receptor
  • Uptake and function of anthrax toxins
  • VEGFR2 mediated vascular permeability
  • VEGFR2 mediated cell proliferation
  • Phase 0 - rapid depolarisation
  • Ion homeostasis
  • CLEC7A (Dectin-1) induces NFAT activation
  • CLEC7A (Dectin-1) induces NFAT activation
  • RHO GTPases activate IQGAPs
  • RHO GTPases activate PAKs
  • RHO GTPases activate PAKs
  • RAF activation
  • RAF/MAP kinase cascade
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by BRAF and RAF1 fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Glycogen breakdown (glycogenolysis)
  • Glycogen breakdown (glycogenolysis)
  • Protein methylation
  • Extra-nuclear estrogen signaling
  • Loss of phosphorylation of MECP2 at T308
  • Regulation of MECP2 expression and activity
  • Ion transport by P-type ATPases
  • Negative regulation of NMDA receptor-mediated neuronal transmission
  • Activation of RAC1 downstream of NMDARs
  • Activation of RAC1 downstream of NMDARs
  • Activation of AMPK downstream of NMDARs
  • Long-term potentiation
  • Long-term potentiation
  • RAS processing
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • FCGR3A-mediated IL10 synthesis
  • FCGR3A-mediated IL10 synthesis
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Chlorpromazine
  • Cinchocaine
  • Nicardipine
  • Fluphenazine
  • Isoflurane
  • Trifluoperazine
  • Loperamide
  • Perphenazine
  • Phenoxybenzamine
  • Felodipine
  • Melatonin
  • Promethazine
  • Pimozide
  • Nifedipine
  • Bepridil
  • Calcium
  • Aprindine
  • Deacetoxyvinzolidine
  • tert-butanol
  • Trimethyllysine
  • N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide
  • Prenylamine
  • Flunarizine
  • (3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE
  • Myristic acid
  • Calcium citrate
  • Calcium citrate
  • Calcium citrate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium Phosphate
  • Calcium levulinate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
  • Calcium phosphate dihydrate
COPB1 COPI coat complex subunit beta 1
  • Neutrophil degranulation
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
COPB2 COPI coat complex subunit beta 2
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
DDR2 discoidin domain receptor tyrosine kinase 2
  • Non-integrin membrane-ECM interactions
  • Regorafenib
  • Fostamatinib
EGFR epidermal growth factor receptor
  • Signaling by ERBB2
  • Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
  • Signaling by ERBB4
  • SHC1 events in ERBB2 signaling
  • SHC1 events in ERBB2 signaling
  • PLCG1 events in ERBB2 signaling
  • PIP3 activates AKT signaling
  • Signaling by EGFR
  • GRB2 events in EGFR signaling
  • GAB1 signalosome
  • SHC1 events in EGFR signaling
  • EGFR downregulation
  • GRB2 events in ERBB2 signaling
  • PI3K events in ERBB2 signaling
  • EGFR interacts with phospholipase C-gamma
  • EGFR Transactivation by Gastrin
  • Constitutive Signaling by Aberrant PI3K in Cancer
  • Signal transduction by L1
  • Constitutive Signaling by EGFRvIII
  • Inhibition of Signaling by Overexpressed EGFR
  • RAF/MAP kinase cascade
  • ERBB2 Regulates Cell Motility
  • PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
  • ERBB2 Activates PTK6 Signaling
  • Cargo recognition for clathrin-mediated endocytosis
  • Clathrin-mediated endocytosis
  • PTK6 promotes HIF1A stabilization
  • Downregulation of ERBB2 signaling
  • TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
  • Extra-nuclear estrogen signaling
  • NOTCH3 Activation and Transmission of Signal to the Nucleus
  • HCMV Early Events
  • Estrogen-dependent nuclear events downstream of ESR-membrane signaling
  • Signaling by ERBB2 KD Mutants
  • Signaling by ERBB2 ECD mutants
  • Signaling by ERBB2 TMD/JMD mutants
  • Cetuximab
  • Lidocaine
  • Gefitinib
  • Erlotinib
  • Lapatinib
  • Panitumumab
  • Alvocidib
  • IGN311
  • Matuzumab
  • Vandetanib
  • Rindopepimut
  • Canertinib
  • Pelitinib
  • Varlitinib
  • AV-412
  • S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
  • PD-168393
  • Afatinib
  • Osimertinib
  • Necitumumab
  • Foreskin keratinocyte (neonatal)
  • Depatuxizumab mafodotin
  • Icotinib
  • Neratinib
  • Dacomitinib
  • Fostamatinib
  • Zalutumumab
  • Brigatinib
  • Olmutinib
  • Zanubrutinib
  • Abivertinib
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
GABBR1 gamma-aminobutyric acid type B receptor subunit 1
  • Activation of G protein gated Potassium channels
  • G alpha (i) signalling events
  • Class C/3 (Metabotropic glutamate/pheromone receptors)
  • GABA B receptor activation
  • Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
  • Baclofen
  • Progabide
  • Taurine
  • gamma-Aminobutyric acid
  • SGS-742
  • Tezampanel
  • Arbaclofen
  • Arbaclofen Placarbil
GNAI1 G protein subunit alpha i1
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Extra-nuclear estrogen signaling
  • ADORA2B mediated anti-inflammatory cytokines production
  • Guanosine-5'-Diphosphate
  • Tetrafluoroaluminate Ion
GNAI2 G protein subunit alpha i2
  • Adenylate cyclase inhibitory pathway
  • Adenylate cyclase inhibitory pathway
  • ADP signalling through P2Y purinoceptor 12
  • Adrenaline,noradrenaline inhibits insulin secretion
  • Adrenaline,noradrenaline inhibits insulin secretion
  • G alpha (s) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
  • Regulation of insulin secretion
  • Extra-nuclear estrogen signaling
  • ADORA2B mediated anti-inflammatory cytokines production
GNAO1 G protein subunit alpha o1
  • Ca2+ pathway
  • Ca2+ pathway
GNAQ G protein subunit alpha q
  • PLC beta mediated events
  • PLC beta mediated events
  • G-protein activation
  • Acetylcholine regulates insulin secretion
  • Acetylcholine regulates insulin secretion
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • ADP signalling through P2Y purinoceptor 1
  • ADP signalling through P2Y purinoceptor 1
  • Thromboxane signalling through TP receptor
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Thrombin signalling through proteinase activated receptors (PARs)
  • Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding
KRIT1 KRIT1 ankyrin repeat containing
MPZ myelin protein zero
  • EGR2 and SOX10-mediated initiation of Schwann cell myelination
OSMR oncostatin M receptor
  • IL-6-type cytokine receptor ligand interactions
PFDN2 prefoldin subunit 2
  • Prefoldin mediated transfer of substrate to CCT/TriC
PLCB1 phospholipase C beta 1
  • PLC beta mediated events
  • PLC beta mediated events
  • Synthesis of IP3 and IP4 in the cytosol
  • Acetylcholine regulates insulin secretion
  • Acetylcholine regulates insulin secretion
  • Ca2+ pathway
  • G alpha (q) signalling events
  • G alpha (q) signalling events
  • G beta:gamma signalling through PLC beta
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion
  • Presynaptic function of Kainate receptors
PTAFR platelet activating factor receptor
  • Class A/1 (Rhodopsin-like receptors)
  • G alpha (q) signalling events
  • Interleukin-10 signaling
  • Neutrophil degranulation
  • Interferon gamma signaling
  • Platelet Activating Factor
  • Etizolam
  • Rupatadine
RRM1 ribonucleotide reductase catalytic subunit M1
  • Interconversion of nucleotide di- and triphosphates
  • Cladribine
  • Gemcitabine
  • Clofarabine
  • Hydroxyurea
  • Fludarabine
  • Imexon
  • Gallium maltolate
  • Tezacitabine
SDHC succinate dehydrogenase complex subunit C
  • Respiratory electron transport
  • Citric acid cycle (TCA cycle)
  • 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol
  • Ubiquinone Q1
UAP1 UDP-N-acetylglucosamine pyrophosphorylase 1
  • Synthesis of UDP-N-acetyl-glucosamine
  • Uridine-Diphosphate-N-Acetylgalactosamine
  • Uridine-Diphosphate-N-Acetylglucosamine